Agents and Actions

, Volume 11, Issue 1–2, pp 144–146 | Cite as

Biochemical studies on histaminergic systems in mammalian brains

  • M. Garbarg
  • G. Barbin
  • E. Rodergas
  • J. C. Schwartz
Article

Abstract

The effects of (±)α-fluoromethylhistidine (α-FMH), a new histidine decarboxylase (HD) inhibitor, were investigated in vitro and in vivo. Following a preincubation with (±)α-FMH, brain HD-activity was progressively inhibited and could not be restored by dialysis, thus indicating the irreversible nature of this inhibition, Moreover, in vivo, a single intraperitoneal dose of 20 mg/kg of (±)α-FMH induced a complete and rapid loss of HD activity in gastric and brain tissues. The time-course of recovery was different according to the tissue studied. At a dose of 100mg/kg (±)α-FMH did not modify histamine-N-methyl transferase (HMT), DOPA decarboxylase and glutamate decarboxylase activities.

A high affinity binding of3H-histamine was seen in particulate fractions from rat brains. The regional and subcellular distributions of these binding sites indicate that they are not related to HMT. They are likely to represent post-synaptic HA-receptors in view of their decrease after kainate-induced degeneration of neuronal perikarya in the striatum and their increase following interruption of the histaminergic inputs which suggested a denervation hypersensitivity. However, their pharmacological specificity was distinct from either H1-or H2-receptors, and the possibility of a modified conformational state of HA-receptors was raised by the selective effect of guanylnucleotides.

Keywords

Glutamate Dopa Particulate Fraction High Affinity Binding Subcellular Distribution 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    J.C. Schwartz,Histamine Receptors, Life Sci.25, 895–912 (1979).PubMedGoogle Scholar
  2. [2]
    M. Baudry, M.P. Martres andJ.C. Schwartz,The Subcellular Localization of Histidine Decarboxylase in Various Regions of Rat Brain, J. Neurochem.21, 1301–1309 (1973).PubMedGoogle Scholar
  3. [3]
    K.M. Taylor andS.H. Snyder,Isotopic Microassay of Histamine, Histidine, Histidine Decarboxylase and Histamine Methyltransferase in Brain Tissue, J. Neurochem.19, 1343–1358 (1972).PubMedGoogle Scholar
  4. [4]
    D. Aures, R. Håkanson andA. Schauer,Histidine Decarboxylase and DOPA Decarboxylase in the Rat Stomach. Properties and Cellular Localization, Eur. J. Pharmac.3, 217–234 (1968).Google Scholar
  5. [5]
    J.R. Moskal andS. Basu,The Measurement of Glutamate Decarboxylase Activity in Brain Tissues by a Simple Microradiometric Method, Anal. Biochem.65, 449–457 (1975).PubMedGoogle Scholar
  6. [6]
    J. Kollonitsch, A.A. Patchett, S. Marburg, A.L. Maycock, L.M. Perkins, G.A. Doldouras, D.E. Duggan andS.D. Aster,Selective Inhibitors of Biosynthesis of Aminergic Neurotransmitters, Nature274, 906–908 (1978).PubMedGoogle Scholar
  7. [7]
    M. Garbarg, G. Barbin, E. Rodergas andJ.C. Schwartz,Inhibition of Histamine Synthesis in Brain by α-Fluoromethylhistidine, a New Irreversible Inhibitor: in vitro and in vivo Studies, J. Neurochem.35(5), 1045–1052 (1980).PubMedGoogle Scholar
  8. [8]
    G. Barbin, J.M. Palacios, E. Rodergas, J.C. Schwartz andM. Garbarg,Characterization of the High Affinity Binding Sites of 3 H-Histamine in Rat Brain, Mol. Pharmac.18, 1–10 (1980).Google Scholar

Copyright information

© Birkhäuser Verlag 1981

Authors and Affiliations

  • M. Garbarg
    • 1
  • G. Barbin
    • 1
  • E. Rodergas
    • 1
  • J. C. Schwartz
    • 1
  1. 1.Unité 109 de NeurobiologieCentre Paul Broca de l'INSERM 2terParisFrance

Personalised recommendations